Steven Lichtman
Stock Analyst at William Blair
(4.78)
# 568
Out of 4,634 analysts
999
Total ratings
54.2%
Success rate
14.6%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintained: Hold | n/a | $6.57 | - | 16 | Aug 7, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | n/a | $97.78 | - | 73 | Aug 6, 2026 | |
| SGHT Sight Sciences | Maintained: Buy | n/a | $7.70 | - | 4 | Aug 6, 2026 | |
| PODD Insulet | Maintained: Buy | n/a | $142.85 | - | 65 | Aug 5, 2026 | |
| DXCM DexCom | Maintained: Buy | n/a | $87.65 | - | 90 | Jul 31, 2026 | |
| SYK Stryker | Maintained: Buy | n/a | $345.81 | - | 53 | Jul 31, 2026 | |
| BFLY Butterfly Network | Maintained: Buy | n/a | $9.70 | - | 1 | Jul 31, 2026 | |
| GKOS Glaukos | Maintained: Buy | n/a | $181.42 | - | 16 | Jul 30, 2026 | |
| MMED MiniMed Group | Maintained: Buy | n/a | $19.50 | - | 2 | Jun 17, 2026 | |
| COO The Cooper Companies | Maintained: Buy | n/a | $76.32 | - | 30 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.24 | - | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $58.32 | - | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $15 | $3.93 | +281.68% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $118 | $50.46 | n/a | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7.5 | $15.33 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $78 | $86.15 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $116 | $89.75 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $16 | $15.75 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $325.98 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $25.12 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $94 | $89.41 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $22.81 | n/a | 43 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.07 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $2.00 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.86 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.70 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.71 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $278.40 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.6797 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.42 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8003 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.44 | n/a | 1 | Oct 7, 2011 |
RxSight
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $6.57
Upside: -
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $97.78
Upside: -
Sight Sciences
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $7.70
Upside: -
Insulet
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $142.85
Upside: -
DexCom
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $87.65
Upside: -
Stryker
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $345.81
Upside: -
Butterfly Network
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $9.70
Upside: -
Glaukos
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $181.42
Upside: -
MiniMed Group
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $19.50
Upside: -
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $76.32
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $24.24
Upside: -
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $58.32
Upside: -
Sep 5, 2025
Maintained: Buy
Price Target: $12 → $15
Current: $3.93
Upside: +281.68%
Aug 3, 2025
Maintained: Hold
Price Target: $118
Current: $50.46
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $11 → $7.5
Current: $15.33
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $73 → $78
Current: $86.15
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $87 → $116
Current: $89.75
Upside: n/a
Jan 10, 2025
Maintained: Buy
Price Target: $13 → $16
Current: $15.75
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $325.98
Upside: n/a
Nov 1, 2024
Maintained: Hold
Price Target: n/a
Current: $25.12
Upside: n/a
Aug 21, 2024
Maintained: Hold
Price Target: $92 → $94
Current: $89.41
Upside: n/a
Aug 2, 2024
Maintained: Buy
Price Target: $58
Current: $22.81
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.07
Upside: n/a
Sep 19, 2023
Maintained: Buy
Price Target: $3.5
Current: $2.00
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $1.86
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $1.70
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $7.71
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $278.40
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $0.6797
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $1.42
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.8003
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $1.44
Upside: n/a